Placeholder Banner

New PBS Film and 2016 BIO Animal Biotech Summit Highlight Biotech Solutions to Combating Emerging Infectious Diseases

August 1, 2016

Washington, D.C. (August 01, 2016) – More than 60 percent of infectious diseases in humans are spread from animals, and 75 percent of the emerging human pathogens are also expected to be zoonotic. HIV and Ebola are modern day examples of viruses that originated in animals and spread to humans.  Even though most zoonotic diseases are not as deadly as HIV/AIDS, all strain public health resources, and some harm a region’s economy and even threaten national security. The severity of the problems posed by emerging zoonotic disease is the focus of a new PBS film, Spillover: Ebola, Zika and Beyond, that will premiere on August 3, 2016.

Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility biotechnology provides for treating, controlling and preventing these diseases. The 2016 Summit will be held September 21-23, 2016 in Bethesda, Maryland.

“As we have seen in this past decade, zoonotic diseases can emerge or re-appear anywhere and at any point without warning. They are a threat to global health, and all countries must have access to the latest technologies in order to identify the pathogenic agents accurately and respond quickly and effectively,” said Adrianne Massey, PhD, Managing Director, Science and Regulatory Affairs at BIO. “The ‘Emerging and Existing Infectious Disease’ Session on September 21 consists of a strong line-up of experts, some of whom are featured in the new PBS film.” 

Topics and confirmed speakers include:

  • Dennis Carroll, Director, Global Health Security and Development Unit, USAID – Dr. Carroll will speak about new genomic tools that allow public health officials to predict outbreaks and respond proactively.
  • Eddie Sullivan, President/CEO, SAB Biotherapeutics – Dr. Sullivan will describe how animals genetically engineered to produce fully humanized antibodies could allow rapid production of large amounts of effective therapeutics. 
  • James Cummings, Senior Director, Novavax – Dr. Cummings will discuss Novavax’s promising work to create a vaccine against the Ebola virus.
  • Haydn Parry, President/CEO, Oxitec – Mr. Parry will provide recent field trials results for genetically engineered mosquitoes. If successful, this strategy could decrease spread of diseases such as dengue fever and Zika.

All Animal Biotech Summit sessions are open to credentialed media. Complimentary media registration is available to editors and reporters with valid press credentials working full time for print, broadcast or web publications.  Registration for reporters has officially opened.

 

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Discover More
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…